What's New on the FDA Drugs Site

May 20, 2011

FDA approves new HIV treatment
FDA approves Sutent (sunitinib) for rare type of pancreatic cancer
FDA Drug Safety Podcast for Healthcare Professionals: Updated Risk Evaluation and Mitigation Strategy (REMS) to Restrict Access to Rosiglitazone-containing Medicines including Avandia, Avandamet, and Avandaryl
New and Generic Drug Approvals

May 20, 2011

Aldactazide (spironolactone and hydrochlorothiazide) Tablets, Pfizer, Inc., Labeling Revision
Azor (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo, Inc., Labeling Revision
Benicar (olmesartan medoxomil) Tablets, Daiichi Sankyo, Labeling Revision
Capoten (captopril) Tablets, Par Pharmaceutical, Inc., Labeling Revision
Humalog (insulin lispro [rDNA origin]) Injection, Eli Lilly and Co., Labeling Revision
Humalog Kwikpen (insulin lispro [rDNA origin]) Injection, Eli Lilly and Co., Labeling Revision
Humalog Pen (insulin lispro [rDNA origin]) Injection, Eli Lilly and Co., Labeling Revision
Teveten HCT (eprosartan mesylate and hydrochlorothiazide) Tablets, Abbott Laboratories, Labeling Revision
Uniretic (moexipril hydrochloride and hydrochlorothiazide) Tablets, UCB, Inc., Labeling Revision
Victoza (liraglutide [rDNA origin]) Subcutaneous Solution, Novo Nordisk, Inc., Labeling Revision